ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 318800 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 318800; 2) Community: the network communities that were significantly associated with the response to NSC 318800; 3) Molecule: the relationships between components within communities and NSC 318800; 4) MDR: the compounds that were significantly associated with the NSC 318800.

NSC Compound Enrichment Correlation
NSC 169774 Bromocriptine methanesulfonate 0.0410413740044188 0.26058436
NSC 20200 [Diisobutyl(phenoxyethoxy)ethyl]dimethylbenzylammonium chloride 0.0410413740044188 0.22422938
NSC 290193 CYCLOSPORIN A 0.0410413740044188 0.31716853
NSC 291330 Null 0.0410413740044188 0.14547188
NSC 294979 BLEOMYCIN-BAPP 0.0410413740044188 0.20206777
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.0410413740044188 -0.02012809
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.0410413740044188 0.02836925
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.0410413740044188 0.36036705
NSC 348121 4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- 0.0410413740044188 0.13642674
NSC 618659 Null 0.0410413740044188 0.29472339
Total:62  Current:54    [First] [Prev] [Next] [Last]